A double-blind, randomized, placebo-controlled, two arm, phase II clinical trial in parallel groups to evaluate the efficacy and tolerability of a rectal treatment with budesonide suppositories compared to placebo suppositories for amelioration of acute radiation proctitis symptoms in male patients aged 18 years or older with prostate carcinoma - BUS-006/RAP
Latest Information Update: 17 Mar 2026
At a glance
- Drugs Budesonide (Primary)
- Indications Ulcerative proctitis
- Focus Therapeutic Use
- Sponsors Dr Falk Pharma
Most Recent Events
- 16 Mar 2026 New trial record